Brexit To Force Large-Scale Review Of Medtech Contractual Arrangements Throughout EU
Executive Summary
UK companies, and firms in the EU dealing with them, need to be prepared to renegotiate their relationships in the context of Brexit, lawyer Alison Dennis tells the sector.
You may also be interested in...
Brexit: Where Things Stand For Medtech
UK and EU leaders announced some progress on Brexit this week, establishing a conditional transition period after the UK exits the Union in 2019. But that does not resolve many questions and concerns in the medtech space about what's to come. Here is a comprehensive look at where things stand for medtech, based a discussion from this week's Device Week podcast.
Commission Spells Out Non-Recognition Of UK Organizations In Future EU
While the details of UK's Brexit deal are not finalized, those paralyzed in disbelief at the enormity of the fallout will have to act. The European Commission spells out the upheaval necessary for medtech to realign into the EU-27.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.